Terkko Navigator / Current Opinion in Pulmonary Medicine

Editorial introductions.

Rapid eye movement sleep and neuronal development.

Unilateral phrenic nerve stimulation in the therapeutical algorithm of central sleep apnoea in heart failure.

Noninvasive volume-assured pressure support for chronic respiratory failure: a review.

A contemporary review of obstructive sleep apnea.

Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea.

Obesity and sleep: a growing concern.

Ethical, philosophical, and practical considerations in adherence to therapy in sleep medicine.

Cardiovascular consequences of obstructive sleep apnea in different study models and novel perspectives.

Sleep and interstitial lung disease.

Diagnosis and management of nonrapid eye movement-parasomnias.

Prevention of chronic infection with Pseudomonas aeruginosa infection in cystic fibrosis.

Prevention of transmission of Mycobacterium abscessus among patients with cystic fibrosis.

Prevention of anxiety and depression in cystic fibrosis.

Prevention of osteoporosis in cystic fibrosis.

Prevention of drug-related complications in cystic fibrosis.

Prevention of malnutrition in cystic fibrosis.

Indwelling pleural catheters for benign pleural effusions: what is the evidence? Erratum.

Editorial introductions.

The global view.

The role of rehabilitation in patients with pulmonary arterial hypertension.

Malnutrition in pulmonary arterial hypertension: a possible role for dietary intervention.

The right treatment for the right ventricle.

Abandoning developmental silos: what can paediatricians and adult interstitial lung disease physicians learn from each other?.

Visual vs. computer-based computed tomography analysis for the identification of functional patterns in interstitial lung diseases.

Critical reappraisal of underlying histological patterns in patients with suspected idiopathic pulmonary fibrosis.

New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?.

Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis.

Pulmonary hypertension due to interstitial lung disease.

Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects.

Patient perspectives in sarcoidosis.

The diagnosis of sarcoidosis.

Advanced sarcoidosis.

Indications for treatment of sarcoidosis.

Treatment of cardiac sarcoidosis.

Approach to tapering antisarcoidosis therapy.

Nonorgan manifestations of sarcoidosis.

Clustering of immune-mediated diseases in sarcoidosis.

Editorial introductions.

The global view.

The role of rehabilitation in patients with pulmonary arterial hypertension.

Malnutrition in pulmonary arterial hypertension: a possible role for dietary intervention.

The right treatment for the right ventricle.

Abandoning developmental silos: what can paediatricians and adult interstitial lung disease physicians learn from each other?.

Visual vs. computer-based computed tomography analysis for the identification of functional patterns in interstitial lung diseases.

Critical reappraisal of underlying histological patterns in patients with suspected idiopathic pulmonary fibrosis.

New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?.

Shaping the future of an ultra-rare disease: unmet needs in the diagnosis and treatment of pulmonary alveolar proteinosis.

Pulmonary hypertension due to interstitial lung disease.

Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects.